Radiotherapy in prostatic carcinoma
De Mûelenaere, G.F.; Sandison, A.G.; Coetzee, F.C.
South African Medical Journal 48(8): 321-324
1974
ISSN/ISBN: 0256-9574 PMID: 4814513 Document Number: 72869
Document emailed within 1 workday
Related Documents
Cellini, N. 1993: External or interstitial radiotherapy: what indications for the management of prostatic carcinoma? Rays 18(1): 81-87Schröder, F.H.; Jellinghaus, W.; Frohmüller, H. 1976: The treatment of locally confined prostatic carcinoma: radiotherapy versus total prostatectomy Der Urologe. Ausg. a 15(2): 67-72
Zelefsky, M.J.; Leibel, S.A.; Kutcher, G.J.; Kelson, S.; Ling, C.C.; Fuks, Z. 1995: The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma Cancer Journal from Scientific American 1(2): 142-150
Cellini, N.; Luzi, S.; Morganti, A.G.; Balducci, M.; Caiazza, A.; Salvi, G.; Trodella, L.; Valentini, V. 1997: Neoadjuvant combined hormonal therapy and radiotherapy with external beam irradiation in prostatic carcinoma La Radiologia Medica 93(4): 446-450
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Weinberg, D.S.; Weidner, N. 1993: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma Archives of Pathology and Laboratory Medicine 117(11): 1132-1137
Ferraris, V.; Pacilli, N.; Bottero, G.; Novella, V.; Pisano, P.F.; Buffa, G. 1994: Treatment of prostatic carcinoma in clinical stage C. Comparison between radiotherapy plus hormonal therapy after progression and immediate hormonal therapy Minerva Urologica e Nefrologica 46(2): 123-128
Shimazaki, J.; Fuse, H.; Akimoto, S.; Sumiya, H.; Akakura, K.; Ichikawa, T. 1988: Prostatic carcinoma. I: Androgen dependency of prostatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-1): 909-916
Sáenz de Chirife, A.M.; Bassi, A.M.; Celeste, F.; Bergdolt, D. 1991: Specific prostatic antigen in prostatic carcinoma: its relationship with tumor differentiation and clinical course Archivos Espanoles de Urologia 44(4): 405-409
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Bologna, M.; Festuccia, C.; Vicentini, C.; Muzi, P.; Biordi, L.; De Nicola, G.; Ventura, T. 1991: Establishment and characterization of a human prostatic carcinoma cell strain obtained from exfoliated tumor cells after prostatic massage Tumori 77(1): 70-75
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Miyazaki, T.; Kato, H.; Faried, A.; Sohda, M.; Nakajima, M.; Fukai, Y.; Masuda, N.; Manda, R.; Fukuchi, M.; Ojima, H.; Tsukada, K.; Kuwano, H. 2005: Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma Anticancer Research 25(4): 2749-2755
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273
Shiran, M.S.; Tan, G.C.; Sabariah, A.R.; Rampal, L.; Phang, K.S. 2007: P63 as a complimentary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions Medical Journal of Malaysia 62(1): 36-39
Sauer, R. 1978: Preoperative radiotherapy and curative radiotherapy without mastectomy in carcinoma of the breast Rontgen-Blatter; Zeitschrift für Rontgen-Technik und Medizinisch-Wissenschaftliche Photographie 31(7): 417-422
Montemaggi, P.; Smaniotto, D.; Luzi, S.; Morganti, A.G. 1991: Combined external radiotherapy and intracavitary radiotherapy in esophageal carcinoma Rays 16(1): 36-41
Schubert, J.; Gorski, J. 1983: Zum biologischen Verhalten des Prostatakarzinoms. II: Klinisch-operative Studien zur lymphogenen Metastasierung des Prostatakarzinoms - Le comportement biologique du cancer prostatique. II: Etudes clinicochirurgicales sur les métastases lymphogènes du cancer prostatique - Biological behaviour of prostatic carcinoma. II. Clinical operative studies of lymphatic metastasizing of prostatic carcinoma der Urologe. Ausgabe a 22: 356-359